Jones-Tabah, J., He, K., Karpilovsky, N., Senkevich, K., Deyab, G., Pietrantonio, I., Goiran, T., Cousineau, Y., Nikanorova, D., Goldsmith, T., del Cid Pellitero, E., Chen, C. X.-Q., Luo, W., You, Z., Abdian, N., Ahmad, J., Ruskey, J. A., Asayesh, F., Spiegelman, D., … Fon, E. A. (2024). The Parkinson’s disease risk gene cathepsin B promotes fibrillar alpha-synuclein clearance, lysosomal function and glucocerebrosidase activity in dopaminergic neurons. Molecular Neurodegeneration, 19(1). https://doi.org/10.1186/s13024-024-00779-9

Ma, Y., Farris, C. M., Weber, S., Schade, S., Nguyen, H., Pérez-Soriano, A., Giraldo, D. M., Fernández, M., Soto, M., Cámara, A., Painous, C., Muñoz, E., Valldeoriola, F., Martí, M. J., Clarimon, J., Kallunki, P., Ma, T. C., Alcalay, R. N., Gomes, B. F., … Concha-Marambio, L. (2024). Sensitivity and specificity of a seed amplification assay for diagnosis of multiple system atrophy: a multicentre cohort study. The Lancet Neurology, 23(12), 1225–1237. https://doi.org/10.1016/s1474-4422(24)00395-8

Coughlin, D. G., MacLeod, K. R., Middleton, J. S., Bozoki, A. C., Galvin, J. E., Irwin, D. J., Lippa, C. F., Litvan, I., Lopez, O. L., Berman, S., Tsuang, D. W., Zabetian, C. P., Honig, L. S., Marder, K. S., Fleisher, J. E., Sabbagh, M., Wint, D., Taylor, A. S., Bekris, L., … Galasko, D. (2024). Association of CSF α-Synuclein Seeding Amplification Assay Results With Clinical Features of Possible and Probable Dementia With Lewy Bodies. Neurology, 103(3). https://doi.org/10.1212/wnl.0000000000209656

Cook, L., Verbrugge, J., Schwantes-An, T.-H., Schulze, J., Foroud, T., Hall, A., Marder, K. S., Mata, I. F., Mencacci, N. E., Nance, M. A., Schwarzschild, M. A., Simuni, T., Bressman, S., Wills, A.-M., Fernandez, H. H., Litvan, I., Lyons, K. E., Shill, H. A., Singer, C., … Alcalay, R. N. (2024). Parkinson’s disease variant detection and disclosure: PD GENEration, a North American study. Brain, 147(8), 2668–2679. https://doi.org/10.1093/brain/awae142

Fu, C., Yang, N., Chuang, J.-Z., Nakajima, N., Iraha, S., Roy, N., Wu, Z., Jiang, Z., Otsu, W., Radu, R. A., Yang, H. H., Lee, M. P., Worgall, T. S., Xiong, W.-C., & Sung, C.-H. (2024). Mutant mice with rod-specific VPS35 deletion exhibit retinal α-synuclein pathology-associated degeneration. Nature Communications, 15(1). https://doi.org/10.1038/s41467-024-50189-0

Barbuti, P. A. (2024). A-Syn(ful) MAM: A Fresh Perspective on a Converging Domain in Parkinson’s Disease. International Journal of Molecular Sciences, 25(12), 6525. https://doi.org/10.3390/ijms25126525

Wise, R. M., Wagener, A., Fietzek, U. M., Klopstock, T., Mosharov, E. V., Zucca, F. A., Sulzer, D., Zecca, L., & Burbulla, L. F. (2022). Interactions of dopamine, iron, and alpha-synuclein linked to dopaminergic neuron vulnerability in Parkinson’s disease and Neurodegeneration with Brain Iron Accumulation disorders. Neurobiology of Disease, 175, 105920. https://doi.org/10.1016/j.nbd.2022.105920

Hallacli, E., Kayatekin, C., Nazeen, S., Wang, X. H., Sheinkopf, Z., Sathyakumar, S., Sarkar, S., Jiang, X., Dong, X., Di Maio, R., Wang, W., Keeney, M. T., Felsky, D., Sandoe, J., Vahdatshoar, A., Udeshi, N. D., Mani, D. R., Carr, S. A., Lindquist, S., … Khurana, V. (2022). The Parkinson’s disease protein alpha-synuclein is a modulator of processing bodies and mRNA stability. Cell, 185(12), 2035-2056.e33. https://doi.org/10.1016/j.cell.2022.05.008

Garretti, F., Monahan, C., Sette, A., Agalliu, D., & Sulzer, D. (2022). T cells, α-synuclein and Parkinson disease. Neuroplasticity - From Bench to Bedside, 439–455. https://doi.org/10.1016/b978-0-12-819410-2.00023-0